Review
Open access
Aug 2026
Looking back on the history of epidermal growth factor receptor mutations in lung cancer.
Despite ongoing challenges owing to drug resistance, novel therapeutic strategies and rational drug combinations continue to redefine the treatment landscape, such that the treatment of EGFR-driven lung cancer remains a paradigm for the application of precision medicine to cancer.
Roy S. Herbst, Meina Wang, Katerina Politi
· Philosophical transactions o... · 1 citation